Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Medimetriks Pharmaceuticals, a developer and marketer of prescription skincare products, has launched its first prescription topical therapies into the dermatology and podiatry markets.
Subscribe to our email newsletter
The three new brands are Pacnex wash, a topical treatment for acne; Sumaxin cleansing pads, a topical treatment for acne, rosacea and seborrheic dermatitis; and Uramaxin nail gel, a treatment for diseased and damaged nails.
According to the company, the vehicles for Pacnex wash and Sumaxin cleansing pads both contain green tea and aloe, natural ingredients gaining wide acceptance. Green tea is known for its antioxidant properties and aloe for its natural soothing benefits. Uramaxin nail gel offers a vehicle containing menthol, camphor and eucalyptus oil, ingredients designed to naturally mask the odor often associated with diseased nails, according to the company.
With the launch of these brands into the dermatology and podiatry markets, Medimetriks said that it will begin to establish a leadership role in supporting the dermatology and podiatry communities. Medimetriks is planning for the launch of additional topical prescription therapies in the first quarter of 2009.
Bradley Glassman, president and CEO of Medimetriks, said: Since the launch of our company eight months ago, Medimetriks’s staff has leveraged its expertise to create and bring to market high-quality topical therapies that offer elegant formulations, provide value to patients, and enhance patient care.
These brands were developed with the objective of meeting the therapeutic needs of both physicians and their patients, and we believe we have developed three brands that meet that objective.